In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation
- PMID: 16257222
- DOI: 10.1016/j.nbd.2005.09.007
In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation
Abstract
Adverse outcome in bacterial meningitis is associated with the breakdown of the blood-brain barrier (BBB). Matrix-metalloproteinases (MMPs) facilitate this process by degradation of components of the BBB. This in turn results in acute complications of bacterial meningitis including edema formation, increased intracranial pressure and subsequent ischemia. We determined the parenchymal balance of MMP-9 and TIMP-1 (tissue inhibitor of MMP) and the structural integrity of the BBB in relation to cortical damage in an infant rat model of pneumococcal meningitis. The data demonstrate that the extent of cortical damage is significantly associated with parenchymal gelatinolytic activity and collagen type IV degradation. The increased gelatinolysis was found to be associated with a brain parenchymal imbalance of MMP-9/TIMP-1. These findings provide support to the concept that MMPs mediated disruption of the BBB contributes to the pathogenesis of bacterial meningitis and that protection of the vascular unit may have neuroprotective potential.
Similar articles
-
Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke.Neuroscience. 2008 Jan 24;151(2):340-51. doi: 10.1016/j.neuroscience.2007.10.006. Epub 2007 Oct 18. Neuroscience. 2008. PMID: 18160227
-
Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis.Brain Res. 2008 May 1;1207:237-43. doi: 10.1016/j.brainres.2008.01.106. Epub 2008 Mar 4. Brain Res. 2008. PMID: 18374903
-
[Relationship between the changes in ischemia/reperfusion cerebro-microvessel basement membrane injury and gelatinase system in senile rat].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 Nov;20(11):656-9. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008. PMID: 19000419 Chinese.
-
[Metalloproteinases in meningoencephalitis].Przegl Epidemiol. 2008;62(2):401-6. Przegl Epidemiol. 2008. PMID: 18807487 Review. Polish.
-
Experimental studies of pneumococcal meningitis.Dan Med Bull. 2010 Jan;57(1):B4119. Dan Med Bull. 2010. PMID: 20175949 Review.
Cited by
-
Combined therapy with ceftriaxone and doxycycline does not improve the outcome of meningococcal meningitis in mice compared to ceftriaxone monotherapy.BMC Infect Dis. 2020 Jul 13;20(1):505. doi: 10.1186/s12879-020-05226-w. BMC Infect Dis. 2020. PMID: 32660552 Free PMC article.
-
The Role of Matrix Metalloproteinase in Inflammation with a Focus on Infectious Diseases.Int J Mol Sci. 2022 Sep 11;23(18):10546. doi: 10.3390/ijms231810546. Int J Mol Sci. 2022. PMID: 36142454 Free PMC article. Review.
-
Targeting brain-peripheral immune responses for secondary brain injury after ischemic and hemorrhagic stroke.J Neuroinflammation. 2024 Apr 18;21(1):102. doi: 10.1186/s12974-024-03101-y. J Neuroinflammation. 2024. PMID: 38637850 Free PMC article. Review.
-
Immune cell infiltration and modulation of the blood-brain barrier in a guinea pig model of tuberculosis: Observations without evidence of bacterial dissemination to the brain.PLoS One. 2024 Dec 31;19(12):e0307577. doi: 10.1371/journal.pone.0307577. eCollection 2024. PLoS One. 2024. PMID: 39739680 Free PMC article.
-
Combining Ceftriaxone with Doxycycline and Daptomycin Reduces Mortality, Neuroinflammation, Brain Damage, and Hearing Loss in Infant Rat Pneumococcal Meningitis.Antimicrob Agents Chemother. 2019 Jun 24;63(7):e00220-19. doi: 10.1128/AAC.00220-19. Print 2019 Jul. Antimicrob Agents Chemother. 2019. PMID: 31061158 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous